$MFC

TSX at All-Time High: Here Are Two Stocks That Still Offer Long-Term Upside

The S&P/TSX Composite rose 3.3% to a record 36,381, its best week in four months. The article highlights Manulife Financial (MFC) with Q2 core earnings up 12% to C$1.9B, core EPS up 16%, ROE 16.3%, and a C$61.78 price. It also cites Air Canada (AC) with Q1 revenue C$5.8B and free cash flow C$1.6B, trading near C$26.58.

Original reporting
Published Aug 15, 2026, 4:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 15, 2026, 1:41 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
TSX at All-Time High: Here Are Two Stocks That Still Offer Long-Term Upside — source image
Decision brief

The 30-second read

$MFCBullishLow
01

Why it matters

Manulife’s reported earnings growth and a specific long-term-care risk transfer are the clearest fundamental positives. Air Canada’s record revenue and free cash flow plus a low trailing P/E are positioned as a potential earnings-driven re-rating, but the piece is still primarily a long-term setup.

02

Market read

This is a stock-selection article tied to a broad Canadian market rally, with two company-specific fundamentals highlighted rather than a new, time-critical corporate event.

03

What to watch

For Manulife, the market may focus on execution and remaining risk sensitivity beyond the transferred biometric component. For Air Canada, trailing P/E can look cheap even if earnings quality or forward margins are pressured.

Relevance 4/10Novelty 4/10Timing: after the TSX index closes at a record 36,381 on Friday

Background

The TSX Composite Index hit a weekly high and a record close, prompting FOMO, but the article argues some individual stocks remain attractively valued.

Company-level read

Ticker impact

$MFCBullishMedium confidence
Context

Manulife reports Q2 core earnings up 12% and agrees to transfer C$3.2B of long-term-care biometric risk to Munich Re, reducing legacy uncertainty.

Expected impact

Mildly positive bias; likely supports dips rather than driving a one-day repricing.

Evidence & confidence

The text provides specific earnings growth and a concrete balance-sheet/risk reduction transaction, but it is presented as a long-term compounding setup, not a fresh surprise print or immediate guidance change.

Market effects

Supports a “second-stage” rotation thesis into quality earnings growers within Canadian financials and travel/transport.

Reinforces positive sentiment around Canadian equities following a strong weekly TSX move.

Limited direct global spillover; mainly a Canada-specific stock selection narrative.

Counterpoint

The article’s “still offers upside” framing may underweight that both names are exposed to macro and cost shocks (insurance risk sensitivity, airline fuel and labor).

Key entities

  • Manulife Financial

    Q2 core earnings and EPS growth, plus a C$3.2B biometric risk transfer to Munich Re to reduce long-term-care risk sensitivity.

  • Air Canada

    Record Q1 revenue and free cash flow, trading near 52-week highs with about a 10x trailing earnings multiple.

  • S&P/TSX Composite Index

    Closed at a record 36,381 after gaining 3.3% on the week.

Related articles

$MFCMedAI 8/10

Manulife CQS touts double-digit SRT returns in US$1 billion pitch

Manulife CQS Investment Management seeks $1 billion for its CQS Regulatory Capital Relief Fund IV, targeting 13% annual returns. The fund invests in significant risk transfers (SRTs), which are growing in popularity among banks to offload risk. SRT sales in 2026's first half surpassed $18 billion, according to Crescent Capital Group LP.

$MFCMedAI 8/10

Manulife (MFC) Q2 2026 Earnings Call Transcript

Manulife Financial (MFC) reported Q2 2026 results on an earnings call. Core EPS rose 16% YoY on 12% core earnings growth and share buybacks. Net income was $2.1B. APE sales grew 21% YoY, and adjusted book value per share was $41.12. The company transacted $3.2B LTC reserves with Munich Re and returned $1.4B to shareholders.

$MFCMed

Manulife Financial Q2 Earnings Call Highlights

Manulife Financial’s Q2 earnings call covered Hong Kong sales mix, China regulatory/tax enforcement questions, and Global Wealth and Asset Management flows. Manulife reported CAD 4 billion net inflows in Global WAM, core earnings up 9%, and LICAT 136%. It also announced a Munich Re reinsurance deal transferring CAD 3.2 billion long-term care reserves and expects CAD 30 million foregone core earnings in year one.

$MFCMedAI 8/10

Manulife Reports Second Quarter 2026 Results

Manulife Financial Corp (MFC) reported 2Q26 results for the quarter ended June 30, 2026. Core earnings were $1.9B, up 12% on a CER basis, and core EPS was $1.09, up 16% y/y. Net income to shareholders was $2.1B. APE sales rose 21% and new business CSM and NBV increased 16% and 10% y/y, respectively.

$MFCMed

Tuesday’s analyst upgrades and downgrades

TD Cowen analyst Mario Mendonca raised targets for Canadian insurers, citing strong equity markets and expected Q2/26 earnings growth. Great-West Lifeco (GWO) target to $98, Manulife (MFC) to $65, Sun Life (SLF) to $121, IA Financial (IAG) to $214. Stifel lifted copper price forecasts to $6.04/lb in 2026 and raised targets for CS, ERO, FM, FCX, HBM. National Bank Financial upgraded Tidewater Midstream (TWM) to Outperform.

$BBMed

TSX Today: What to Watch for in Stocks on Tuesday, June 2

Canadian stocks opened June mixed as investors weighed Middle East geopolitical risks and uncertainty around U.S.-Iran talks, with energy markets in focus. The S&P/TSX Composite fell 34 points (0.1%) to 34,735. Equinox Gold, Orla Mining, G Mining Ventures and CCL Industries dropped over 6% each. Parex Resources rose 10% to $26.52 after completing a US$500m Frontera Energy acquisition adding 37,000 boe/d and supporting 2026 guidance.